Total Voting Rights

Summary by AI ^BETAClose X

Sherborne Investors (Guernsey) C Limited has announced the purchase of 35,855,824 ordinary shares at an average price of 35.0p and an additional 2,201,665 shares at 34.5p, with all acquired shares to be cancelled. Following these transactions, the total number of shares with voting rights in issue as of 30 January 2026 stands at 652,018,633, which shareholders should use for disclosure notification calculations.

Disclaimer*

Sherborne Investors (Guernsey)C Ltd

30 January 2026

Sherborne Investors (Guernsey) C Limited

LEI 213800L8QL59OCFOCB40

30 January 2026

Sherborne Investors (Guernsey) C Limited

Total Voting Rights

Sherborne Investors (Guernsey) C Limited (the "Company") announces that, on 29 January 2026, the Company purchased 35,855,824 of its ordinary shares of no par value ("Shares") at an average price, before fees and commissions, of 35.0p per share and on 30 January 2026, the Company purchased 2,201,665 of its Shares at an average price, before fees and commissions, of 34.5p per share. All purchased Shares will be cancelled.

On 30 January 2026 the total number of Shares with voting rights in issue in the Company was 652,018,633. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

-Ends-

Enquiries:

DGA Group +44 (0)20 7664 5095

Jonathon Brill

James Styles

Deutsche Numis (Broker) +44 (0)20 7260 1000

Nathan Brown

George Shiel

Sherborne Investors (Guernsey) C Limited +44 (0)20 3530 3600

Talmai Morgan (Chair)

Matt Lihou (Apex, Company Secretary)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END